financetom
Business
financetom
/
Business
/
Looking At CVS Health's Recent Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking At CVS Health's Recent Unusual Options Activity
Oct 7, 2024 10:15 AM

Benzinga's options scanner just detected over 14 options trades for CVS Health ( CVS ) summing a total amount of $1,086,658.

At the same time, our algo caught 8 for a total amount of 829,553.

Expected Price Movements

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $67.5 for CVS Health ( CVS ), spanning the last three months.

Volume & Open Interest Trends

In terms of liquidity and interest, the mean open interest for CVS Health ( CVS ) options trades today is 2289.09 with a total volume of 6,639.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for CVS Health's ( CVS ) big money trades within a strike price range of $30.0 to $67.5 over the last 30 days.

CVS Health 30-Day Option Volume & Interest Snapshot

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
CVS PUT TRADE BULLISH 01/16/26 $5.75 $5.1 $5.1 $57.50 $255.0K 3.0K 1.0K
CVS PUT TRADE BULLISH 01/16/26 $5.9 $5.1 $5.1 $57.50 $255.0K 3.0K 500
CVS CALL SWEEP BEARISH 09/19/25 $10.15 $9.1 $9.22 $62.50 $92.4K 449 100
CVS CALL SWEEP BULLISH 10/11/24 $0.83 $0.73 $0.73 $66.00 $91.0K 1.6K 1.5K
CVS CALL SWEEP BULLISH 10/11/24 $1.27 $1.21 $1.26 $65.00 $74.2K 4.6K 250

About CVS Health

CVS Health ( CVS ) offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

In light of the recent options history for CVS Health ( CVS ), it's now appropriate to focus on the company itself. We aim to explore its current performance.

Where Is CVS Health Standing Right Now?

With a volume of 5,093,857, the price of CVS is up 0.2% at $64.72.

RSI indicators hint that the underlying stock may be overbought.

Next earnings are expected to be released in 30 days.

Professional Analyst Ratings for CVS Health

A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $67.75.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from Cantor Fitzgerald downgraded its action to Neutral with a price target of $62.

* In a positive move, an analyst from TD Cowen has upgraded their rating to Buy and adjusted the price target to $85.

* In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Neutral, setting a price target of $62.

* In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Neutral, setting a price target of $62.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for CVS Health ( CVS ) with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's commerce minister meets Apple CEO
China's commerce minister meets Apple CEO
Mar 20, 2026
BEIJING, March 20 (Reuters) - China's Commerce Minister Wang Wentao met Apple ( AAPL ) Chief Executive Tim Cook in Beijing on Friday, the ministry said. We are very appreciative of government incentives that are stimulating consumption, Cook told Wang while stressing the importance of the Chinese market for Apple ( AAPL ), a video posted by the ministry showed....
SWI Group secures €260M capital increase in relation to the expansion to North America of its AI & data center strategy
SWI Group secures €260M capital increase in relation to the expansion to North America of its AI & data center strategy
Mar 20, 2026
AMSTERDAM, March 20, 2026 /PRNewswire/ -- Further to the announcement on 24 February 2026 in relation to SWI Capital Holding Ltd.'s (SWI) acquisition of a significant stake in a US data center company (TargetCo), SWI announces today that it has entered into binding agreements with its founder and majority shareholder, Max-Hervé George (the Founder), and co-investor and existing shareholder, Aliya Fund...
Market Chatter: Microsoft-Backed OpenAI Plans to Combine Desktop Applications
Market Chatter: Microsoft-Backed OpenAI Plans to Combine Desktop Applications
Mar 20, 2026
04:30 AM EDT, 03/20/2026 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is preparing to combine its ChatGPT interface, Codex program, and its web browser into a singular desktop platform to streamline organizational resources, The Wall Street Journal reported Thursday, citing a company spokeswoman and an internal note. Applications head Fidji Simo will direct the product revamp alongside President...
Tarsus Pharmaceuticals Insider Sold Shares Worth $892,528, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $892,528, According to a Recent SEC Filing
Mar 20, 2026
04:30 AM EDT, 03/20/2026 (MT Newswires) -- Aziz Mottiwala, Chief Commercial Officer, on March 17, 2026, sold 13,056 shares in Tarsus Pharmaceuticals ( TARS ) for $892,528. Following the Form 4 filing with the SEC, Mottiwala has control over a total of 61,480 common shares of the company, with 61,480 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819790/000178854226000007/xslF345X05/wk-form4_1773961455.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved